European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“ESMOAI26 : How can AI transform cancer research and patient care responsibly?
We invite researchers, clinicians, data scientists, digital health specialists, and industry innovators to submit their abstracts and contribute to critical discussions on:
- AI innovation in oncology
- Human-AI interaction
- Ethical and regulatory considerations
- Real-world deployment
- Agentic and autonomous AI systems
Share your findings and help advance the future of oncology.
Submit your abstract by 1 September 2026.”
Other articles from European Society for Medical Oncology (ESMO) on OncoDaily.